Glenmede Trust’s Zogenix, Inc. ZGNX Stock Holding History

Glenmede Trust’s Portfolio ZGNX Stock Details ZGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,173	Closed	-$21K	–	2579
2020 Q3	$21K	Sell	1,173 -42	-3%	-$1.03K	﹤0.01%	1616
2020 Q2	$32K	Buy	+1,215	New	+$33.5K	﹤0.01%	1432
2019 Q4	–	Sell	-36	Closed	-$1	–	3241
2019 Q3	$1	Hold	36	–	–	﹤0.01%	2977
2019 Q2	$1	Hold	36	–	–	﹤0.01%	3030
2019 Q1	$1	Buy	+36	New	+$1.71K	﹤0.01%	3014

Other funds holding ZGNX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Glenmede Trust's ZGNX Position: Q4 2020 in Review

Glenmede Trust sold out of Zogenix, Inc. (ZGNX) in Q4 2020, closing a stake of 1,173 shares — an estimated $21K sold.

Glenmede Trust first reported a position in ZGNX in Q1 2019 and held it in 5 quarters. The position peaked at $32K in Q2 2020. 159 funds tracked by Wall St. Rank hold ZGNX as of Q4 2020.

Glenmede Trust reported no remaining Zogenix, Inc. position as of Q4 2020 after selling out during the quarter.
Glenmede Trust sold 1,173 Zogenix, Inc. shares in Q4 2020, an estimated $21K.
Glenmede Trust first reported a position in Zogenix, Inc. in Q1 2019 and held it in 5 quarters.
Glenmede Trust's Zogenix, Inc. position peaked at $32K in Q2 2020.
159 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q4 2020.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.